Tech Company Financing Transactions

SpringLeaf Therapeutics Funding Round

On 5/12/2011, SpringLeaf Therapeutics raised $15 million in Series A financing from SR One Capital Management, Flybridge Capital Partners and North Bridge Venture Partners.

Transaction Overview

Announced On
5/12/2011
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors

SR One Capital Management (Lead Investor) (Brian Gallagher)

Flybridge Capital Partners (Michael Greeley)

North Bridge Venture Partners (Jeffrey MCCARTHY)

Proceeds Purpose
We have achieved promising preclinical results to date and anticipate clinical testing to initiate in late 2012. With the support of our new and existing investors, SpringLeaf is well positioned to advance our proprietary program, transforming the way patients are treated.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
8 St. Mary's Street 601
Boston, MA 02215
USA
Email Address
Overview
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics.
Profile
SpringLeaf Therapeutics LinkedIn Company Profile
Social Media
SpringLeaf Therapeutics Company Twitter Account
Company News
SpringLeaf Therapeutics News
Facebook
SpringLeaf Therapeutics on Facebook
YouTube
SpringLeaf Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Garen Bohlin
  Garen Bohlin LinkedIn Profile  Garen Bohlin Twitter Account  Garen Bohlin News  Garen Bohlin on Facebook
Co-Founder
Yet-Ming Chiang
  Yet-Ming Chiang LinkedIn Profile  Yet-Ming Chiang Twitter Account  Yet-Ming Chiang News  Yet-Ming Chiang on Facebook
Co-Founder
Michael Cima
  Michael Cima LinkedIn Profile  Michael Cima Twitter Account  Michael Cima News  Michael Cima on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/12/2011: MoMelan Technologies venture capital transaction
Next: 5/12/2011: Lightbend venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary